Core Viewpoint - Hiab Corporation has received all necessary regulatory approvals for the sale of its MacGregor business, with the transaction expected to close on July 31, 2025 [1][2]. Group 1: Transaction Details - The agreement to sell the MacGregor business was initially announced on November 14, 2024, to funds managed by Triton [1]. - As of July 1, 2025, all regulatory approvals have been secured, except for the approval from the Chinese State Administration for Market Regulation (SAMR) [1][2]. - MacGregor has been classified as part of discontinued operations since the fourth quarter of 2024 [2]. Group 2: Company Overview - Hiab Corporation is a leading provider of smart and sustainable on-road load-handling solutions, with a commitment to delivering excellent customer experiences [2]. - The company operates globally, with a network of 3,000 sales and service locations, enabling delivery to over 100 countries [2]. - In 2024, Hiab's continuing operations generated sales of approximately EUR 1.6 billion and employed over 4,000 people [2].

The event can also be viewed as a live webcast at https://hiab.events.inderes.com/q2-2025. A recording of the event will be published on Hiab's website later during the day. Please note that by dialling into the conference call, the participant agrees that personal information such as name and company name will be collected. For further information, please contact: Oscar Törnwall, IR Manager, Tel. +358 40 7050 894, oscar.tornwall(at)hiab.com Hiab (Nasdaq Helsinki: HIAB) is a leading provider of smart and su ...

Core Insights - Corbion has secured multiple regulatory approvals from China's General Administration of Customs (GACC) for its algae-derived omega-3 DHA solutions, enabling entry into the Chinese market for both human and animal nutrition segments [1][2] - The products, marketed under the AlgaPrime™ DHA and AlgaVia™ DHA brands, are designed to meet the increasing demand for high-quality, sustainable nutrition solutions in China [1][2] Company Overview - Corbion is a sustainable ingredients company focused on preserving food, health, and the planet, specializing in lactic acid, food preservation solutions, and algae ingredients [3] - The company generated annual sales of €1,332.0 million in 2024 and employs 2,399 full-time equivalents [3] Product Details - AlgaVia™ DHA and AlgaPrime™ DHA are produced from microalgae through controlled fermentation using sugar cane and renewable energy, reducing reliance on marine resources and minimizing carbon footprint [2] - These omega-3 solutions are available in various formats, including powder, liquid suspension, and oil, catering to diverse applications in human and animal nutrition [2]

魔芋等创新产品上新提速，胖东来验证健 康标签 核心观点 盈利预测与投资建议 ⚫ 我们预测公司 2025–2027 年 EPS 分别为 0.74/ 0.84/ 1.00 元（原 25/26 年预测值为 0.79/0.98 元）下调 25–26 年盈利预测，主要反映以下两点：一是 2025Q1 业绩短 期承压，毛利率略降而销售及财务费用率同比提升，显示费用投放节奏相对前置； 二是公司持续加码新品研发、品牌投入与渠道深化（如胖东来、高端会员店等）， 短期内对盈利形成阶段性扰动。考虑长期成长逻辑未改，参考可比公司估值水平， 给予公司 2025 年 20 倍 PE，对应目标价 14.8 元，维持"买入"评级。 风险提示 居民消费力不及预期；行业竞争加剧风险；渠道拓展不及预期风险；原材料价格波动等 风险等。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 2,065 | 2,412 | 2,816 | 3,248 | 3,713 | | 同比增长 (%) | 4 ...

Group 1 - WTI August crude oil futures closed at $67.00 per barrel [1] - Abu Dhabi Murban crude oil futures are currently down 0.28%, trading at $70.03 per barrel as of 02:31 Beijing time [1] - NYMEX August natural gas futures closed at $3.4090 per million British thermal units [1] Group 2 - NYMEX August gasoline futures closed at $2.1186 per gallon [1] - NYMEX August heating oil futures closed at $2.3698 per gallon [1]

Core Viewpoint - The company Baolingbao (002286) is currently facing challenges in the market, with its stock price at 12.55 yuan, down 2.03%, and significant trading activity noted on July 3, 2025 [1] Group 1: Company Developments - The company clarified that its DHA algal oil production does not strictly fall under the definition of marine economy as outlined in the national marine economic development plan [1] - Baolingbao's product, Alotose, has not yet been approved for sale in the domestic market, and the approval timeline for its enzyme preparation remains uncertain [1] - The company has submitted an application for the domestic approval of its Alotose enzyme preparation, but it is still pending [1] Group 2: Market Activity - On July 3, 2025, the net outflow of main funds from Baolingbao was 102 million yuan, while speculative funds saw a net inflow of 26.07 million yuan, and retail investors contributed a net inflow of 75.65 million yuan [1]

Core Viewpoint - Selay is redefining the dietary supplement industry with a focus on personalized health solutions, combining natural ingredients with scientific innovation to cater to diverse consumer needs [1][5][7] Group 1: Product Philosophy - Selay emphasizes the importance of pure, natural ingredients sourced from plants and animals, ensuring high quality through rigorous selection processes [3] - The brand utilizes organic materials from local German farms and high-purity fish oil from Norway, achieving an Omega-3 content of 95% with minimal heavy metal residues [3] Group 2: Targeted Product Lines - Selay offers personalized product lines for various demographics, including blood sugar balance capsules for the elderly, hormone-regulating drinks for women, vitality supplements for men, and growth drinks for children [5] - Each product is designed to address specific health needs, such as cardiovascular health, metabolic balance, and developmental support for children [5] Group 3: Consumer Impact - The "Selay Arginine Capsule" exemplifies the brand's approach, combining ingredients like maca, arginine, oyster peptides, and zinc to significantly enhance physical strength and energy levels [7] - Selay aims to provide health solutions that resonate with different lifestyles, from busy professionals to health-conscious homemakers, ensuring that everyone can find their ideal health answer [7] Group 4: Future Outlook - The company is committed to ongoing research and innovation, with plans to expand its product line and offer more precise and effective nutritional solutions [7] - Selay envisions a future where health is easily accessible, promoting a lifestyle that harmonizes scientific advancements with natural wellness [7]

Core Points - Hiab Corporation announced an update on the closing timetable for the sale of its MacGregor business to funds managed by Triton, with the transaction subject to regulatory approvals [1] - Regulatory approvals have been obtained from various jurisdictions, including the European Union, but approval from the Chinese State Administration for Market Regulation (SAMR) is still pending [2] - The closing of the transaction is now expected by 1 October 2025, which is later than the initially expected date of 1 July 2025 [2] - MacGregor has been reported as part of discontinued operations since the fourth quarter of 2024, and the updated closing timetable is not expected to have a significant financial impact on the company [3] Company Overview - Hiab is a leading provider of smart and sustainable on-road load handling solutions, with a commitment to delivering the best customer experience [3] - The company has a global presence with an extensive network of 3,000 own and partner sales and service locations, enabling delivery to over 100 countries [3] - Hiab's continuing operations sales in 2024 totaled approximately EUR 1.6 billion, and the company employs over 4,000 people [3]

Core Insights - WTI August crude oil futures rose by $0.32, an increase of over 0.49%, closing at $65.24 per barrel [1] - Abu Dhabi Murban crude oil futures increased by 0.50%, currently priced at $68.42 per barrel as of 02:35 Beijing time [1] - NYMEX July natural gas futures fell approximately 4.26%, settling at $3.2610 per million British thermal units [1] - NYMEX July gasoline futures closed at $2.0990 per gallon, while NYMEX July heating oil futures settled at $2.3601 per gallon [1]

公司预计半年报营收与去年同期持平，但利润端将延续一季度盈利趋势， 主要受益于成本下降和费用管控，尤其电商渠道投流费用大幅削减，利 润贡献显著。 各渠道利润率排序为：专卖店 > 省外商超（山姆等）> 零食量贩 ≈ 电 商 > 大宗商品。山姆渠道黑金枣单品月销已达 1,500 万元，若全渠道 铺货，月销有望翻倍至 3,000 万元。 永辉、天虹等商超调整后，推行"胖东来同款"标准品，对公司产品销 售产生积极影响，无需更换包装直接采购公司标品。 DHA 藻油产品于 2025 年二季度在山姆部分门店试销，预计全国铺货后 月销售额可达 2000 万元。另有红枣奶酪组合等 2-3 款新品储备，预计 中秋节期间推出。 公司改变原材料采购策略，由一次性采购全年用量改为按季度或月度小 批量采购，以降低风险。毛利率能及时反映当季采购成本下降，预计三、 四季度毛利率仍有上升空间。 2025 年公司战略核心是保利润，通过严格的费用管控（特别是电商渠 道）和"创收创立产品"清单，实现扭亏为盈，利润考核权重显著提升。 公司坚持"红枣加健康溯源食品"战略，以红枣为核心进行产品研发， 并利用富余产能尝试开发其他品类，如粉面类食品、粥类产品、 ...